Andrej A Romanovsky Selected Research

Fever (Fevers)

1/2022	The hyperthermic effect of central cholecystokinin is mediated by the cyclooxygenase-2 pathway.
1/2018	Fever and hypothermia in systemic inflammation.
1/2017	Cold-Induced Thermogenesis and Inflammation-Associated Cold-Seeking Behavior Are Represented by Different Dorsomedial Hypothalamic Sites: A Three-Dimensional Functional Topography Study in Conscious Rats.
10/2015	Platelet-activating factor is a potent pyrogen and cryogen, but it does not mediate lipopolysaccharide fever or hypothermia.
1/2015	Hyperbilirubinemia exaggerates endotoxin-induced hypothermia.
1/2013	Lipopolysaccharide-induced neuronal activation in the paraventricular and dorsomedial hypothalamus depends on ambient temperature.
7/2012	Neural circuitry engaged by prostaglandins during the sickness syndrome.
6/2012	Naturally occurring hypothermia is more advantageous than fever in severe forms of lipopolysaccharide- and Escherichia coli-induced systemic inflammation.
8/2009	Cyclooxygenase-1 or -2--which one mediates lipopolysaccharide-induced hypothermia?
4/2008	Fever response to intravenous prostaglandin E2 is mediated by the brain but does not require afferent vagal signaling.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrej A Romanovsky Research Topics

Disease

32	Fever (Fevers) 01/2022 - 01/2002
18	Inflammation (Inflammations) 01/2022 - 03/2003
18	Hypothermia 01/2020 - 11/2003
10	Hyperthermia 01/2022 - 08/2003
4	Pain (Aches) 09/2013 - 05/2008
3	Hyperalgesia 11/2017 - 07/2012
2	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2021 - 10/2018
2	Wounds and Injuries (Trauma) 01/2019 - 08/2010
2	Infections 01/2019 - 04/2008
2	Shock 01/2017 - 08/2010
2	Anorexia 07/2012 - 08/2004
2	Sepsis (Septicemia) 01/2012 - 10/2008
2	Neoplasms (Cancer) 08/2010 - 05/2008
1	Hypoxia (Hypoxemia) 01/2019
1	Hypercapnia 01/2019
1	Burns 01/2019
1	Hypersensitivity (Allergy) 11/2017
1	Panic Disorder (Panic Attack) 01/2017
1	Hyperbilirubinemia 01/2015
1	Nausea 03/2014
1	Vomiting 03/2014
1	Sleepiness 07/2012
1	Communicable Diseases (Infectious Diseases) 07/2012
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2012
1	Necrosis 05/2011
1	Heart Diseases (Heart Disease) 08/2010
1	Emphysema 08/2010

Drug/Important Bio-Agent (IBA)

22	LipopolysaccharidesIBA 01/2022 - 01/2002
8	Dinoprostone (PGE2)FDA Link 01/2018 - 03/2003
8	ProstaglandinsIBA 10/2015 - 11/2002
6	EnzymesIBA 10/2006 - 11/2002
5	EndotoxinsIBA 01/2022 - 01/2004
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022 - 11/2005
4	PyrogensIBA 01/2018 - 08/2003
4	Capsaicin (Zostrix)FDA Link 01/2010 - 12/2003
4	Prostaglandins EIBA 08/2009 - 03/2003
3	Cholecystokinin (Pancreozymin)IBA 01/2022 - 03/2003
3	Dimenhydrinate (DMH)FDA LinkGeneric 01/2017 - 12/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 12/2004
3	EphA1 Receptor (Eph Receptor)IBA 07/2006 - 04/2005
3	EphrinsIBA 07/2006 - 04/2005
3	Proteins (Proteins, Gene)FDA Link 09/2005 - 03/2003
2	Cholecystokinin B ReceptorIBA 01/2022 - 01/2004
2	Protons (Proton)IBA 01/2020 - 01/2010
2	N- (4- (6- (4- trifluoromethylphenyl)pyrimidin- 4- yloxy)benzothiazol- 2- yl)acetamideIBA 11/2017 - 05/2008
2	SC 560IBA 10/2015 - 08/2009
2	4- (5- (4- chlorophenyl)- 3- (trifluoromethyl)- 1H- pyrazol- 1- yl)benzenesulfonamideIBA 10/2015 - 08/2009
2	Platelet Activating FactorIBA 10/2015 - 11/2003
2	resiniferatoxinIBA 05/2011 - 12/2004
2	capsazepineIBA 05/2011 - 12/2004
2	Nicotine FDA Link 08/2010 - 10/2008
2	TRPV Cation ChannelsIBA 05/2008 - 12/2004
2	Erythropoietin FDA Link 06/2006 - 04/2005
2	LigandsIBA 06/2006 - 04/2005
2	Phosphotransferases (Kinase)IBA 06/2006 - 04/2005
2	TRPV1 receptorIBA 12/2004 - 01/2004
1	YM 022IBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	3- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA 01/2019
1	Morphine (MS Contin)FDA LinkGeneric 11/2017
1	ABT 102IBA 11/2017
1	Analgesics (Analgesic Drugs)IBA 11/2017
1	Opioid Analgesics (Opioids)IBA 11/2017
1	WEB 2086 (apafant)IBA 10/2015
1	Cyclooxygenase 1IBA 10/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2015
1	BilirubinIBA 01/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015
1	Ondansetron (Zofran)FDA LinkGeneric 03/2014
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 03/2014
1	Serotonin (5 Hydroxytryptamine)IBA 03/2014
1	muskIBA 03/2014
1	AMG2850IBA 03/2014
1	Tetrodotoxin (Tetradotoxin)IBA 09/2013
1	4-Aminopyridine (4 Aminopyridine)FDA Link 09/2013
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2013
1	Delayed Rectifier Potassium ChannelsIBA 09/2013
1	Proto-Oncogene Proteins c-fos (FRAs)IBA 01/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2012
1	3- (4- chlorophenyl)- N- methyl- N'- ((4- chlorophenyl)sulfonyl)- 4- phenyl- 4,5- dihydro- 1H- pyrazole- 1- carboxamidineIBA 05/2011
1	SR 144528IBA 05/2011
1	RimonabantIBA 05/2011
1	CB2 Cannabinoid ReceptorIBA 05/2011
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 05/2011
1	SteroidsIBA 08/2010

Therapy/Procedure

5	Induced Hypothermia 10/2021 - 08/2009
3	Therapeutics 01/2010 - 05/2004
2	Injections 01/2019 - 11/2005
2	Ligation 01/2012 - 10/2008
2	Punctures 01/2012 - 10/2008
2	Catheters 11/2005 - 01/2002
2	Vagotomy 01/2004 - 12/2003
1	Induced Hyperthermia (Thermotherapy) 01/2022
1	Antibiotic Prophylaxis 01/2019
1	Anesthesia 11/2017
1	General Anesthesia 11/2017
1	Intravenous Administration 01/2015
1	Radiotherapy 03/2014
1	Mechanical Ventilators (Ventilator) 08/2010
1	Length of Stay 08/2010